We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+8.73%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
AUM
$1.61B
AUM Growth
+$468M
Cap. Flow
+$374M
Cap. Flow %
23.17%
Top 10 Hldgs %
13.38%
Holding
714
New
266
Increased
203
Reduced
191
Closed
54

Top Buys

Rank Stock Value
1
IRBT
iRobot
IRBT
+$7.47M
2
AVB icon
AvalonBay Communities
AVB
+$4.52M
3
PLD icon
Prologis
PLD
+$4.5M
4
SSYS icon
Stratasys
SSYS
+$4.01M
5
EQR icon
Equity Residential
EQR
+$3.99M

Sector Composition

Rank Sector Weight
1 Technology 27.75%
2 Healthcare 15.28%
3 Industrials 11.49%
4 Consumer Discretionary 9.04%
5 Real Estate 8.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGN icon
301
Regeneron Pharmaceuticals
REGN
$80.8B
$1.68M 0.1%
4,476
-443
-9% -$149K
TTMI icon
302
TTM Technologies
TTMI
$14.5B
$1.67M 0.1%
+111,195
New +$1.46M
SRE icon
303
Sempra
SRE
$54.8B
$1.66M 0.1%
21,896
-924
-4% -$67.8K
CLLS
304
Cellectis
CLLS
$285M
$1.66M 0.1%
96,757
+6,793
+8% +$90.7K
HLT icon
305
Hilton Worldwide
HLT
$71.5B
$1.65M 0.1%
+14,892
New +$1.49M
ZYME icon
306
Zymeworks
ZYME
$1.67B
$1.65M 0.1%
36,290
-32,144
-47% -$1.17M
HTT
307
High Templar Tech Ltd
HTT
$391M
$1.65M 0.1%
+349,492
New +$2.06M
WGO icon
308
Winnebago Industries
WGO
$909M
$1.64M 0.1%
+31,022
New +$1.45M
LPT
309
DELISTED
Liberty Property Trust
LPT
$1.64M 0.1%
+27,291
New +$1.56M
MRNA icon
310
Moderna
MRNA
$23.6B
$1.64M 0.1%
83,750
-3,660
-4% -$64.9K
SANM icon
311
Sanmina
SANM
$10.9B
$1.63M 0.1%
+47,730
New +$1.53M
BLUE
312
DELISTED
bluebird bio
BLUE
$1.62M 0.1%
1,429
+549
+62% +$597K
LUMN icon
313
Lumen
LUMN
$6.44B
$1.62M 0.1%
122,520
+11,672
+11% +$157K
WU icon
314
Western Union
WU
$2.21B
$1.61M 0.1%
60,046
+21,679
+57% +$562K
AZN icon
315
AstraZeneca
AZN
$250B
$1.61M 0.1%
16,123
-1,734
-10% -$163K
KN icon
316
Knowles
KN
$3.34B
$1.61M 0.1%
+76,045
New +$1.63M
ATRA icon
317
Atara Biotherapeutics
ATRA
$76.1M
$1.6M 0.1%
3,891
+1,328
+52% +$458K
ARGX icon
318
argenx
ARGX
$54.1B
$1.6M 0.1%
9,974
-1,251
-11% -$169K
FATE icon
319
Fate Therapeutics
FATE
$326M
$1.6M 0.1%
81,695
+1,274
+2% +$20.2K
HUM icon
320
Humana
HUM
$46.2B
$1.59M 0.1%
4,338
+36
+0.8% +$11.4K
CNDT icon
321
Conduent
CNDT
$264M
$1.59M 0.1%
+256,212
New +$1.6M
EXR icon
322
Extra Space Storage
EXR
$31.6B
$1.58M 0.1%
14,968
+4,774
+47% +$521K
AUTL
323
Autolus Therapeutics
AUTL
$562M
$1.57M 0.1%
118,866
+30,953
+35% +$405K
PUMP icon
324
ProPetro Holding
PUMP
$1.35B
$1.57M 0.1%
+139,412
New +$1.25M
CLX icon
325
Clorox
CLX
$12.7B
$1.55M 0.1%
10,125
-95
-0.9% -$14.2K

Similar funds

Vident Investment Advisory's Q4 2019 Portfolio in Review

As of Q4 2019, Vident Investment Advisory held 714 positions worth $1.61B, up 41% from $1.14B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Vident Investment Advisory deployed $374M of net new capital in Q4 2019, opening 266 new positions and adding to 203 existing holdings. Its largest new stake was AvalonBay Communities: 21,114 shares worth $4.43M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Faro Technologies, an estimated $6.68M trimmed.

  • Vident Investment Advisory's largest Q4 2019 buy was AvalonBay Communities: 21,114 shares worth $4.43M.
  • Vident Investment Advisory added most to iRobot in Q4 2019, an estimated $7.47M increase.
  • Vident Investment Advisory's biggest Q4 2019 reduction was Faro Technologies, cutting an estimated $6.68M.
  • Vident Investment Advisory fully exited Nuveen Preferred & Income Securities Fund in Q4 2019, selling an estimated $11.3M.
  • Vident Investment Advisory's ten largest holdings make up 13% of its $1.61B portfolio in Q4 2019.
  • Vident Investment Advisory opened 266 new positions and closed 54 in Q4 2019.
  • Vident Investment Advisory's portfolio value rose 41% quarter-over-quarter to $1.61B.

Based on Vident Investment Advisory's 13F filing for Q4 2019, filed 11 Feb 2020.